Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API’s, Intermediates and Nutraceutical ingredients
Financial Results:
Divi’s Laboratories Ltd reported Revenues for Q1FY24 of ₹1,778.00 Crores down from ₹2,255.00 Crore year on year, a fall of 21.15%.
Total Expenses for Q1FY24 of ₹1,367.00 Crores down from ₹1,491.00 Crores year on year, a fall of 8.32%.
Consolidated Net Profit of ₹356.00 Crores down 49.29% from ₹702.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹13.41, down 49.28% from ₹26.44 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.